Indication

Histology

1 clinical trial

1 product

1 drug

Clinical trial

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff

Status: Recruiting, Estimated PCD: 2025-09-30

Drug

Product